# Phase I/II Study of Capecitabine Plus Aflibercept to Treat Metastatic Colorectal Cancer

> **NCT01661972** · PHASE1,PHASE2 · COMPLETED · sponsor: **John Strickler, M.D.** · enrollment: 63 (actual)

## Conditions studied

- Metastatic Colorectal Cancer

## Interventions

- **DRUG:** Capecitabine and aflibercept

## Key facts

- **NCT ID:** NCT01661972
- **Lead sponsor:** John Strickler, M.D.
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-08
- **Primary completion:** 2016-06-12
- **Final completion:** 2016-06-12
- **Target enrollment:** 63 (ACTUAL)
- **Last updated:** 2018-10-29

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01661972

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01661972, "Phase I/II Study of Capecitabine Plus Aflibercept to Treat Metastatic Colorectal Cancer". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01661972. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*